OVAGEN
Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry & rodent research technologies to GMP standards and in avian transgenics.
OVAGEN
Industry:
Biotechnology
Founded:
2000-01-01
Address:
Mayo, Mayo, Ireland
Country:
Ireland
Website Url:
http://www.ovagen.ie
Total Employee:
1+
Status:
Active
Contact:
+353 (0)96 75579
Email Addresses:
[email protected]
Total Funding:
3.37 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Ovagen
Official Site Inspections
http://www.ovagen.ie
- Host name: 73.0.153.160.host.secureserver.net
- IP address: 160.153.0.73
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Ovagen"
About Us - Ovagen
The Ovagen team has a wealth of technical, operational, financial and management experience. Our Research and Development team has 100 years of combined life-sciences related R&D experience. Ovagen is a biotechnology …See details»
Ovagen - Crunchbase Company Profile & Funding
Organization. Ovagen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number +353 …See details»
Ovagen Company Profile 2024: Valuation, Funding & Investors
Ovagen General Information Description. Operator of a veterinary company intended to develop a process of producing germ-free eggs in commercial quantities used primarily in …See details»
WDC Leads €2m Investment in Ovagen, Pioneering Innovation in …
Oct 30, 2024 Ovagen is a prime example of how WIF investments can catalyse significant advances in technology, attract further private and public investment, and create long-term …See details»
Western Development Commission leads €2m investment in Mayo …
Oct 29, 2024 “Ovagen’s revolutionary technology not only strengthens Ireland’s position as a global leader in biotechnology but also showcases how regional investment can lead to world …See details»
WDC supports €1.1M investment in Mayo biotech …
Feb 3, 2023 Their support, along with the tireless dedication of the Ovagen team, puts us in a very strong position as we prepare to go to market with the world’s first germ-free egg.” Declan MacFadden, spokesperson for HBAN’s …See details»
Western Development Commission leads €2 million investment in …
Oct 29, 2024 Ovagen’s pioneering germ-free eggs eliminate this issue, reducing contamination risks, increasing vaccine yields, and playing a significant role in combating antimicrobial …See details»
Mayo germ-free eggs company raises €1.1m – The …
Feb 3, 2023 Mayo-based Ovagen has raised €1.1 million in funding and said it expects to add 65 jobs in the next five years as it further develops its germ-free eggs.See details»
Ovagen Group Limited secures €10 million funding award from EIC ...
22 nd June 2022, Ballina, Mayo, Ireland – Biotechnology company Ovagen Group Limited has again been awarded European Innovation Council (EIC) Accelerator funding, thanks to a €10 …See details»
WDC leads €2m investment in biotechnology company Ovagen
Oct 29, 2024 The Western Development Commission (WDC) has led a €2 million Series A equity investment round in Ovagen, a biotechnology company based in Ballina, Co Mayo. The …See details»
Cracking success: Mayo firm that developed world’s first germ …
Feb 3, 2023 The world’s first producer of germ-free eggs Ovagen has raised €1.1m in an oversubscribed funding round led by HBAN (Halo Business Angel Network) syndicates Irrus …See details»
EU funding enables Ovagen to tackle global vaccine market
Dec 6, 2022 Ovagen has recently been awarded European Innovation Council (EIC) Accelerator funding of €10 million between Grant and Equity, placing the company in the top 7% of …See details»
Major €2 million investment in Ballina company
Oct 29, 2024 Ovagen’s pioneering germ-free eggs eliminate this issue, reducing contamination risks, increasing vaccine yields, and playing a significant role in combating antimicrobial …See details»
Ballina-based firm to benefit from €2m investment
Nov 5, 2024 Ovagen’s pioneering germ-free eggs eliminate this issue, reducing contamination risks, increasing vaccine yields, and playing a significant role in combating antimicrobial …See details»
The Ovagen Team – Ovagen
Production of germ free eggs and antibodies by Ovagen. 0. Toggle menuSee details»
Mayo biotech firm Ovagen raises €2m | ThinkBusiness
Oct 29, 2024 €2m investment in Ovagen to power innovation in vaccine manufacturing. Ballina-based biotech business Ovagen has raised €2m in a Series A equity investment round led by …See details»
Mayo biotech Ovagen raises €2m and plans to hire 60
Oct 29, 2024 Ovagen, the Mayo-based biotech behind the world’s first germ-free eggs for vaccine development has raised €2m in a Series A equity investment round led by the …See details»
The Process - Ovagen
Ovagen has developed a process to address this anatomical problem of egg contamination with a specialised patented, innovative and disruptive technology which combines the Directors’ …See details»
Irish biotech Ovagen raises €1.1m for germ-free egg production
Feb 8, 2023 Based in Co Mayo, Ovagen now plans to add 65 jobs over the next five years and hopes to see its revenue reach €42m by the end of 2027. Irish biotech start-up Ovagen has …See details»